CN103254173B - 兰索拉唑晶型化合物 - Google Patents
兰索拉唑晶型化合物 Download PDFInfo
- Publication number
- CN103254173B CN103254173B CN201310166993.5A CN201310166993A CN103254173B CN 103254173 B CN103254173 B CN 103254173B CN 201310166993 A CN201310166993 A CN 201310166993A CN 103254173 B CN103254173 B CN 103254173B
- Authority
- CN
- China
- Prior art keywords
- lansoprazole
- ulcer
- crystal compound
- necked flask
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310166993.5A CN103254173B (zh) | 2013-05-08 | 2013-05-08 | 兰索拉唑晶型化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310166993.5A CN103254173B (zh) | 2013-05-08 | 2013-05-08 | 兰索拉唑晶型化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103254173A CN103254173A (zh) | 2013-08-21 |
CN103254173B true CN103254173B (zh) | 2015-04-08 |
Family
ID=48958438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310166993.5A Active CN103254173B (zh) | 2013-05-08 | 2013-05-08 | 兰索拉唑晶型化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103254173B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101475562A (zh) * | 2009-01-21 | 2009-07-08 | 海南美大制药有限公司 | 一种兰索拉唑及其盐的合成方法 |
CN101514199A (zh) * | 2009-03-31 | 2009-08-26 | 张锡芬 | 一种兰索拉唑化合物及其制法 |
CN102180866A (zh) * | 2011-05-23 | 2011-09-14 | 中山大学 | 兰索拉唑新晶型及其制备方法和应用 |
CN102617555A (zh) * | 2012-03-20 | 2012-08-01 | 西藏易明西雅生物医药科技有限公司 | 一种兰索拉唑的制备方法 |
-
2013
- 2013-05-08 CN CN201310166993.5A patent/CN103254173B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101475562A (zh) * | 2009-01-21 | 2009-07-08 | 海南美大制药有限公司 | 一种兰索拉唑及其盐的合成方法 |
CN101514199A (zh) * | 2009-03-31 | 2009-08-26 | 张锡芬 | 一种兰索拉唑化合物及其制法 |
CN102180866A (zh) * | 2011-05-23 | 2011-09-14 | 中山大学 | 兰索拉唑新晶型及其制备方法和应用 |
CN102617555A (zh) * | 2012-03-20 | 2012-08-01 | 西藏易明西雅生物医药科技有限公司 | 一种兰索拉唑的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103254173A (zh) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102212093B (zh) | 黄酮苷类化合物及其制备方法和用途 | |
CN103232438A (zh) | 泮托拉唑钠和制法 | |
CN102617555B (zh) | 一种兰索拉唑的制备方法 | |
CN103919778B (zh) | 一种含哌啶酮结构的姜黄素类似物s1在制备抗炎药物方面的应用 | |
CN103980226A (zh) | 盐酸阿考替胺水合物晶型及其制备方法 | |
CN103254173B (zh) | 兰索拉唑晶型化合物 | |
CN108503644B (zh) | 一种苯并二氮杂*衍生物的氢溴酸盐及其制备方法和用途 | |
CN106478619B (zh) | 一类黄嘌呤氧化酶抑制剂及其应用 | |
KR101500836B1 (ko) | 참나무 분획 복합 추출물 및 이를 유효성분으로 함유하는 당뇨병 치료 또는 예방용 조성물 | |
CN102875615B (zh) | 大麻药苷a和大麻药总皂苷的提取方法及其应用 | |
CN104224863A (zh) | 金钱草总黄酮在制备降低高尿酸血症药物中的应用 | |
CN107375279A (zh) | 新型噻唑类衍生物在治疗炎性肠病中的应用 | |
CN103232436B (zh) | 兰索拉唑晶型化合物制备方法 | |
CN103006648A (zh) | 一种马来酸左旋氨氯地平药物活性组合物及其制备方法 | |
CN103724318B (zh) | 九香虫酰胺a及其组合物和其在制药和食品中的应用 | |
JPH0152363B2 (zh) | ||
CN102552122B (zh) | 一种制备盐酸青藤碱注射剂的方法 | |
US8158168B2 (en) | Anti-gastritis and anti-ulcer agent containing Momordicae semen extract and momordica saponin I isolated from the same | |
US10828304B2 (en) | Compositions and methods for white to beige adipogenesis | |
Fehri et al. | Effects of Globularia alypum L. on the gastrointestinal tract | |
CN102499913B (zh) | 精制纯化的丹皮酚制剂的制备方法 | |
CN106749228A (zh) | 一种小檗碱药物及其制备方法与应用 | |
CN102093380B (zh) | 环淫羊藿素苷元及其制备方法和应用 | |
JP2009520020A5 (zh) | ||
Li et al. | Enhanced therapeutic effect on colitis with powder formulations of Painong San associated with the promotion of intestinal adhesion and absorption |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: Seven of 276017 Shandong province Linyi city Luozhuang District Applicant after: Shandong Luo Xin Pharmaceutical Group Plc Address before: Seven of 276017 Shandong province Linyi city Luozhuang District Applicant before: SHANDONG LUOXIN PHARMACY STOCK Co., LTD. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHANDONG LUOXIN PHARMACY STOCK CO., LTD. TO: SHANDONG LUOXIN PHARMACY GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190531 Address after: 276017 Luoqi Road, Luozhuang District, Linyi City, Shandong Province Co-patentee after: Shandong Luoxin Pharmaceutical Group Hengxin Pharmacy Co., Ltd. Patentee after: Shandong Luo Xin Pharmaceutical Group Plc Co-patentee after: Shandong Yu Xin pharmaceutcal corporation, Ltd Address before: 276017 Luoqi Road, Luozhuang District, Linyi City, Shandong Province Patentee before: Shandong Luo Xin Pharmaceutical Group Plc |